TNYA Stock Discussion

Tenaya Therapeutics, Inc. Description

Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Gene Therapy Biomarkers Heart Failure Heart Disease Personalized Medicine Induced Stem Cells Chemical Pathology